Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Therapeutic Goods > Clinical Trials Oversight > Approved Sites & Centers

Approved Sites & Centers

Last Updated on June 13, 2025

Clinical Studies Site (CTS)

Following clinical trials sites are approved by Clinical studies Committee for conduction of Clinical Trials as mentioned in the table below

17-LIST-OF-APPROVED-CLINICAL-TRIAL-SITES-CTS-2025-06-13Download
Pages: 1 2 3 4 5
  • Drugs
    • Pharmaceutical Drugs
    • Biological Drugs
    • Veterinary Drugs
    • Post Registration Variation
    • Quality Surveillance
    • Application Types
    • Application Processes
    • Approvals & Updates
  • Medical Devices
    • Is It a Medical Device?
    • Risk Classification
    • Device Grouping / Clusters
    • Application Process
    • International Collaboration
    • Approvals & Updates
  • Alternative Medicine
    • Product Categories
    • Application Process
    • Approvals & Updates
  • Controlled Substances
    • Regulate Manufacturing of Controlled Medicines
    • Allocation, Monitoring and Compliance
  • Emergency Use Authorizations
    • EUA for Drugs & Vaccines
    • EUA for Medical Devices
  • Clinical Trials Oversight
    • Clinical Trials
    • Approved Sites & Centers
    • Application Process
    • Serious Adverse Event in Clinical Trials
    • GCP Inspections
    • Clinical Trials Registry
  • Licensing and Inspections
    • Drug Manufacturing License
    • Medical Devices Establishment Licenses
    • Alternative Medicines & Health Products Establishments
    • Application Process
    • Good Practices Compliances (GxP)
    • Approvals & Updates
  • Quality Controls Labs
    • Central Drugs Laboratory
    • National Control Laboratory for Biologicals
    • Federal Drugs Surveillance Lab
    • Provincial Quality control Laboratories
  • Import & Export
    • Authorized Products
    • Special Permissions
  • Advertisement Approvals
    • Regulation of Advertisement of Therapeutic Goods
    • Approvals & Updates

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem